BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 31, 2006
View Archived Issues
MyVax Misses Statistical Hurdle, Genitope Plunges
In a disappointing case of déj vu, investors drove down shares in Genitope Corp. by 48.6 percent after learning that a Phase III study of its lead cancer treatment would last longer than expected. (BioWorld Today)
Read More
Sales Force Layoff 'Neutral' As Neurocrine Marches On
Read More
Radiation-Killed Bacteria Can Elicit T-Cell Immune Response
Read More
As The BioWorld Turns: From White Biotech To Stem Cell Fun
Read More
Cangene Gets $143M HHS Contract For Anthrax Drug
Read More
Other News To Note
Read More